Leiomyomas Clinical Trials

A listing of Leiomyomas medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 92 clinical trials
featured
<ul>
  • A first sign may be a combination of warning signals before the headache appears such as nausea or flashing lights. These “warning signs” may continue through the headache.
  • The

    • 0 views
    • 30 Jul, 2021
    • 1 location
    featured
    Fibromyalgia

    to treat this condition.

     
    Common symptoms of fibromyalgia may include:
    <ul>
  • Widespread pain in multiple body areas
  • Fatigue
  • Disturbed and / or

    fatigue
    fibromyalgia
    • 0 views
    • 30 Jul, 2021
    • 1 location
    featured
    Alzheimer's Disease

    associated with early stages of Alzheimer’s disease:

    <ul>
  • Forgetfulness: forgetting dates, events, names, misplacing or losing things, repeating stories, repeatedly asking the same question
  • alzheimer's disease
    • 0 views
    • 30 Jul, 2021
    • 1 location
    featured
    Mild Cognitive Impairment

    for stopping Alzheimer’s disease.

     
    Mild Cognitive Impairment (MCI), is characterized by:
     
    <ul>
  • Memory problems that may be annoying, frustrating or

    alzheimer's disease
    dementia
    cognitive impairment
    mild cognitive impairment
    progression of alzheimer's disease
    • 0 views
    • 30 Jul, 2021
    • 1 location
    featured
    Depression

    or hopeless) or loss of interest or pleasure most of the day nearly every day.


    Other common symptoms of MDD include:
    <ul>
  • Fatigue
  • Low energy
  • Low

    transcranial magnetic stimulation
    suicidal
    treatment resistant depression
    behavior therapy
    depressive symptoms
    • 0 views
    • 30 Jul, 2021
    • 1 location
    featured
    An Open-Label Evaluation of the Safety and Tolerability of SAGE-718 in Participants with Parkinson’s Disease Mild Cognitive Impairment

    Mild cognitive impairment is a condition that is associated with decreased quality of life, impaired functioning, and is common in people who have Parkinson’s Disease (PD). People with Parkinson’s Disease mild cognitive impairment (PD-MCI) are at a high risk for developing dementia.Your participation in this study will last approximately 7 weeks, including …

    mild cognitive impairment
    dementia
    cognitive impairment
    • 0 views
    • 29 Jul, 2021
    • 2 locations
    featured
    Memory Loss Prevention

    All medications approved by the FDA for Alzheimer’s disease help treat the symptoms or slow down the progression of the disease. There are no treatments that address the underlying cause of the disease.As we learn more about the brain, researchers have been better able to design research programs that target …

    alzheimer's disease
    dementia
    • 0 views
    • 30 Jul, 2021
    • 1 location
    Impact Evaluation of Super Abbu: A Speech Based MNCH Platform in Pakistan

    phone call. This service, dubbed Super Abbu (Super Dad in English), addresses the challenges faced by existing efforts in several new and important ways:

    <ul>
  • The service targets fathers

    • 0 views
    • 31 Jul, 2021
    • 1 location
    Evaluation of a Practice-oriented Recovery Program for Female Endurance Athletes With Relative Energy Deficiency

    The aim of this study is to develop, implement and evaluate the effects of a 16 week practice orientated sports nutrition education and counselling program aiming to improve energy availability and to investigate the effects on physiological and psychological health, sports nutrition knowledge, and athletic performance in well-trained female endurance …

    • 0 views
    • 20 Jul, 2021
    • 4 locations
    A Study of ERAS-007 in Patients With Advanced Non-Small-Cell Lung Cancer

    <ul>

  • To evaluate the safety and tolerability of escalating doses of ERAS-007 in combination with other cancer therapies in study participants with advanced non-small cell lung cancer (NSCLC

    • 0 views
    • 27 Jul, 2021
    • 1 location